Top
Main

All Outcomes

Feedback
Home
Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Cannabidiol  COVID-19 treatment studies for Cannabidiol  C19 studies: Cannabidiol  Cannabidiol   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
Loading...
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc
Supplementary Data — Cannabidiol for COVID-19: real-time meta analysis of 6 studies
Covid Analysis, December 2022
https://c19early.org/cbdmeta.html
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Crippa (DB RCT) -557% 6.57 [0.35-124] hosp. 3/49 0/42 Improvement, RR [CI] Treatment Control Crippa (DB RCT) -33% 1.33 [0.86-2.08] recov. time 49 (n) 42 (n) Nguyen 50% 0.50 [0.31-0.82] cases 26/531 48/531 Nguyen 33% 0.67 [0.49-0.91] cases 75/1,212 108/1,212 Huang -181% 2.81 [1.04-7.58] death n/a n/a Huang 19% 0.81 [0.73-0.90] cases n/a n/a Merianos -212% 3.12 [1.87-4.97] symp. case 94/416 20/384 Merianos -71% 1.71 [1.13-2.49] symp. case 77/416 38/384 Merianos -3% 1.03 [0.96-1.09] cases 367/416 317/384 Lehrer -24% 1.24 [1.05-1.45] cases n/a n/a Shover (PSM) 2% 0.98 [0.94-1.04] death 3/69 199/1,762 Shover (PSM) 5% 0.95 [0.91-0.99] ventilation 3/69 292/1,762 Shover (PSM) 9% 0.91 [0.85-0.99] ICU 8/69 543/1,762 Shover 3% 0.97 [0.92-1.02] oxygen 35/69 1,417/1,762 Cannabidiol COVID-19 outcomes c19early.org/cbd Dec 2022 Favors cannabidiol Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit